Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
Jay T Guevarra, Robert Hiensch, Andrew W Varga, David M Rapoport Division of Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai Integrative Sleep Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USACorrespondence: Jay T GuevarraDivision of Pulmonary, Critical Care, and Sle...
Enregistré dans:
Auteurs principaux: | Guevarra JT, Hiensch R, Varga AW, Rapoport DM |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9e56c7d5904649659b556f6c4e2f56f7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
par: Calik MW
Publié: (2017) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
par: Vellieux G, et autres
Publié: (2021) -
Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects
par: Sahni AS, et autres
Publié: (2019) -
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD
par: Wang YG, et autres
Publié: (2017) -
Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
par: Abad VC
Publié: (2021)